FDA — authorised 15 March 1962
- Marketing authorisation holder: BRACCO
- Status: approved
FDA authorised Ipodate on 15 March 1962
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 15 March 1962.
BRACCO holds the US marketing authorisation.